Background and purpose: The individual dosimetry performed for a multicentr
e European cohort study of second malignant neoplasm following radiotherapy
for a solid cancer in childhood demonstrated a large variation in the radi
ation doses estimated to any site.
Materials and methods: From this study we have extracted the present work,
i.e. estimation of doses for patients who underwent radiotherapy for Hodgki
n's disease in their childhood. These patients were treated using high ener
gy X-rays from linear accelerators (MV group), gamma-radiation from Cobalt
machines (Cobalt group), soft X-rays from orthovoltage machines (kV group)
and electron beams from accelerators (MeV group) at six French and UK centr
es. All patients started their radiotherapy between 1955 and 1985 and about
12% of them received more than one beam quality. Most of the patients were
irradiated with large mantle AP/PA or partial mantle fields. Patients with
transdiaphragmatic extension were also irradiated using inverted-Y paraaor
tic fields. The absorbed doses at the 91 skeleton points are used to calcul
ate the mean dose to the active bone marrow.
Results: Estimates of the median and mean doses, standard deviations and ra
nges to 13 specific sites of the body and to the active bone marrow are rep
orted. Depending upon the size and sex of patients, target volume and posit
ion and radiotherapy techniques, the estimated doses are highly spread, att
aining 0.19-106.07% of the target dose. This study underscores the need for
individual dosimetry in epidemiological studies. Comparison with the avail
able measured and calculated doses to the ovary and testis shows good agree
ment.
Conclusion: This study underscores the need for individual dosimetry in epi
demiological studies. (C) 1998 Elsevier Science Ireland Ltd. All rights res
erved.